To help people lead healthier lives — free from exposure to harmful microorganisms, allergens and pollutants.
Liquim is an Australian research and development company developing natural-origin, plant-based consumer products powered by its patented microfilm barrier technology.
Liquim uses its patented microfilm barrier technology to develop consumer products derived from natural-origin and plant-based ingredients.
Liquim is committed to researching and developing natural-origin, plant-based solutions, with multiple applications intended to support better health, wellbeing, and Environmental, Social and Governance (ESG) outcomes.
Built in Western Australia, for a global problem.
Liquim was founded as an Australian R&D company with a deliberately narrow brief: solve airborne and surface-particle exposure with chemistry the planet can metabolise. The platform was conceived and developed in Perth, with formulation and independent laboratory validation carried out at our Osborne Park laboratory.
The founding intent was practical, not ideological — petroleum-derived disposables and alcohol-heavy sanitisers had become defaults across personal care and personal protective equipment (PPE), with consequences spanning microplastic accumulation, glove decay timelines exceeding a century, and skin and mucosal irritation. Plant-origin chemistry, applied as a mechanical microfilm rather than a pharmacological agent, offered a route around those defaults.
“We started with a single conviction: that protection shouldn't cost the planet a hundred years to undo.”
Our two main criteria.
Scientifically evaluated for people
Every Liquim formulation undergoes laboratory evaluation for skin and mucosal compatibility and is developed in line with the applicable regulatory framework in each launch market.
Gentle on the planet
Every Liquim product is developed to support environmental, social and governance (ESG) outcomes — natural-origin, plant-based, alcohol-free, biodegradable where possible, and packaged responsibly.
When applied, Liquim's microfilm technology forms a thin film on the surface. In its various forms it is designed for use on the mucosal lining and on skin. In independent laboratory evaluations, the film has been shown to maintain barrier integrity against a range of aerosol particle sizes, including very small particles, and against larger particles such as smoke, pollen and dust. These independent laboratory results describe laboratory performance only; they are not a claim that the product prevents, treats or cures any disease in humans,